These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 16697015)

  • 21. APOE epsilon 4 allele is associated with cognitive impairment in patients with multiple sclerosis.
    Shi J; Zhao CB; Vollmer TL; Tyry TM; Kuniyoshi SM
    Neurology; 2008 Jan; 70(3):185-90. PubMed ID: 17460153
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Evaluation of cognitive performance by using P300 auditory event related potentials (ERPs) in patients with growth hormone (GH) deficiency and acromegaly.
    Tanriverdi F; Yapislar H; Karaca Z; Unluhizarci K; Suer C; Kelestimur F
    Growth Horm IGF Res; 2009 Feb; 19(1):24-30. PubMed ID: 18567522
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Cognitive impairment and structural brain damage in benign multiple sclerosis.
    Rovaris M; Riccitelli G; Judica E; Possa F; Caputo D; Ghezzi A; Bertolotto A; Capra R; Falautano M; Mattioli F; Martinelli V; Comi G; Filippi M
    Neurology; 2008 Nov; 71(19):1521-6. PubMed ID: 18815387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Memory decline evolves independently of disease activity in MS.
    Duque B; Sepulcre J; Bejarano B; Samaranch L; Pastor P; Villoslada P
    Mult Scler; 2008 Aug; 14(7):947-53. PubMed ID: 18573817
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Evaluating sub-clinical cognitive dysfunction and event-related potentials (P300) in clinically isolated syndrome.
    Kocer B; Unal T; Nazliel B; Biyikli Z; Yesilbudak Z; Karakas S; Irkec C
    Neurol Sci; 2008 Dec; 29(6):435-44. PubMed ID: 19002651
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cognitive aging in patients with multiple sclerosis: a cross-sectional analysis of speeded processing.
    Bodling AM; Denney DR; Lynch SG
    Arch Clin Neuropsychol; 2009 Dec; 24(8):761-7. PubMed ID: 19820246
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Event-related potentials in the assessment of cognitive function in multiple sclerosis.
    Barrett G; Feinstein A; Jones S; Turano G; Youl B
    Electroencephalogr Clin Neurophysiol Suppl; 1999; 50():469-79. PubMed ID: 10689496
    [No Abstract]   [Full Text] [Related]  

  • 28. Cognitive status in hypothyroid female patients: event-related evoked potential study.
    Anjana Y; Tandon OP; Vaney N; Madhu SV
    Neuroendocrinology; 2008; 88(1):59-66. PubMed ID: 18285681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Progress on neuropsychology and event-related potentials in patients with brain trauma].
    Dong RX; Cai WX; Tang T; Huang FY
    Fa Yi Xue Za Zhi; 2010 Feb; 26(1):51-5. PubMed ID: 20232746
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Diagnostic value of event-related evoked potentials N200 and P300 subcomponents in early diagnosis of Alzheimer's disease and mild cognitive impairment.
    Bennys K; Portet F; Touchon J; Rondouin G
    J Clin Neurophysiol; 2007 Oct; 24(5):405-12. PubMed ID: 17912065
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neuropsychological and electrophysiological indices of neurocognitive dysfunction in bipolar II disorder.
    Andersson S; Barder HE; Hellvin T; Løvdahl H; Malt UF
    Bipolar Disord; 2008 Dec; 10(8):888-99. PubMed ID: 19594504
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
    Patti F; Amato MP; Trojano M; Bastianello S; Tola MR; Goretti B; Caniatti L; Di Monte E; Ferrazza P; Brescia Morra V; Lo Fermo S; Picconi O; Luccichenti G;
    Mult Scler; 2009 Jul; 15(7):779-88. PubMed ID: 19542262
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Event-related potentials and cognitive performance in multiple sclerosis patients with fatigue.
    Pokryszko-Dragan A; Zagrajek M; Slotwinski K; Bilinska M; Gruszka E; Podemski R
    Neurol Sci; 2016 Sep; 37(9):1545-56. PubMed ID: 27271940
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Impairment of source memory in patients with obsessive-compulsive disorder: equivalent current dipole analysis.
    Kim YY; Roh AY; Yoo SY; Kang DH; Kwon JS
    Psychiatry Res; 2009 Jan; 165(1-2):47-59. PubMed ID: 19027963
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Neuropsychological evaluation in multiple sclerosis].
    Arnett P; Forn C
    Rev Neurol; 2007 Feb 1-15; 44(3):166-72. PubMed ID: 17285522
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Electrophysiological diagnostic criteria of multiple sclerosis].
    Dimitri D
    Rev Neurol (Paris); 2001 Sep; 157(8-9 Pt 2):981-6. PubMed ID: 11787364
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Contribution of cognitive evoked potentials for detecting early cognitive disorders in multiple sclerosis].
    Magnié MN; Bensa C; Laloux L; Bertogliati C; Faure S; Lebrun C
    Rev Neurol (Paris); 2007 Nov; 163(11):1065-74. PubMed ID: 18033045
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Cognitive impairment in multiple sclerosis: evidence-based analysis and recommendations.
    Rogers JM; Panegyres PK
    J Clin Neurosci; 2007 Oct; 14(10):919-27. PubMed ID: 17659875
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Neurophysiological correlates of cognitive disturbances in multiple sclerosis.
    Leocani L; Gonzalez-Rosa JJ; Comi G
    Neurol Sci; 2010 Nov; 31(Suppl 2):S249-53. PubMed ID: 20842399
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effects of quetiapine on cognitive functions in schizophrenic patients: a preliminary single-trial ERP analysis.
    Zhang Y; Lehmann M; Shobeiry A; Höfer D; Johannes S; Emrich HM; Dietrich DE
    Pharmacopsychiatry; 2009 Jul; 42(4):129-34. PubMed ID: 19585390
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.